Researchers have presented the results of a multidisciplinary study involving the capture of radiation luminescence and radioactive-excited nanoparticles to help detect subtle signs of disease. Currently, nuclear medicine agents and imaging technology image the behavior of particles at the cellular, molecular and atomic levels, but radioactive materials also emit barely visible light that can be detected with highly sensitive optical imaging technology. This discovery could lead to new, state-of-the-art imaging techniques.